The global clinical laboratory services market size is expected to be valued at US$ 272.1 billion in 2026 and projected to reach US$ 353.3 billion by 2033, growing at a CAGR of 3.8% between 2026 and 2033.

The market expansion is driven by rising prevalence of chronic and infectious diseases worldwide, combined with an aging global population requiring more frequent diagnostic testing. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for 7 out of 10 leading causes of death in the United States, necessitating comprehensive laboratory screening programs. Additionally, technological advancements in laboratory automation and artificial intelligence integration are enhancing diagnostic accuracy and reducing turnaround times, thereby accelerating market adoption across healthcare settings.

The global clinical laboratory services market size is expected to be valued at US$ 272.1 billion in 2026 and projected to reach US$ 353.3 billion by 2033, growing at a CAGR of 3.8% between 2026 and 2033.

The market expansion is driven by rising prevalence of chronic and infectious diseases worldwide, combined with an aging global population requiring more frequent diagnostic testing. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for 7 out of 10 leading causes of death in the United States, necessitating comprehensive laboratory screening programs. Additionally, technological advancements in laboratory automation and artificial intelligence integration are enhancing diagnostic accuracy and reducing turnaround times, thereby accelerating market adoption across healthcare settings.